PDLIM7 and nasopharyngeal carcinoma: LMP1-CTAR1 also activates EGFR and ERK through protein kinase C delta (PKC delta) [113], which promotes NPC cell motility and invasiveness through activation of the ERK-MAPK pathway [129].